In a filing, 10x Genomics Inc revealed its Chief Executive Officer Saxonov Serge unloaded Company’s shares for reported $0.15 million on Aug 22 ’24. In the deal valued at $22.53 per share,6,749 shares were sold. As a result of this transaction, Saxonov Serge now holds 882,467 shares worth roughly $13.36 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hindson Benjamin J. sold 4,351 shares, generating $98,027 in total proceeds. Upon selling the shares at $22.53, the insider now owns 345,704 shares.
Before that, McAnear Justin J. sold 2,961 shares. 10x Genomics Inc shares valued at $66,710 were divested by the Former Chief Financial Officer at a price of $22.53 per share. As a result of the transaction, McAnear Justin J. now holds 143,242 shares, worth roughly $2.17 million.
Leerink Partners initiated its 10x Genomics Inc [TXG] rating to an Outperform in a research note published on September 03, 2024; the price target was $35. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in late July from “a Hold” to “a Buy”. JP Morgan also remained covering TXG and has decreased its forecast on July 18, 2024 with a “Neutral” recommendation from previously “an Overweight” rating. Deutsche Bank revised its rating on July 10, 2024. It rated TXG as “a Hold” which previously was an “a Buy”.
Price Performance Review of TXG
On Tuesday, 10x Genomics Inc [NASDAQ:TXG] saw its stock fall -1.50% to $15.14. Over the last five days, the stock has lost -4.84%. 10x Genomics Inc shares have fallen nearly -72.94% since the year began. Nevertheless, the stocks have fallen -61.61% over the past one year. While a 52-week high of $57.90 was reached on 01/02/24, a 52-week low of $14.02 was recorded on 10/10/24. SMA at 50 days reached $20.84, while 200 days put it at $28.64.
Levels Of Support And Resistance For TXG Stock
The 24-hour chart illustrates a support level at 14.88, which if violated will result in even more drops to 14.62. On the upside, there is a resistance level at 15.45. A further resistance level may holdings at 15.77. The Relative Strength Index (RSI) on the 14-day chart is 31.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.90, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.77%. Stochastics %K at 17.00% indicates the stock is a buying.
How much short interest is there in 10x Genomics Inc?
A steep rise in short interest was recorded in 10x Genomics Inc stocks on 2024-09-30, dropping by -1.51 million shares to a total of 7.44 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 8.94 million shares. There was a decline of -20.24%, which implies that there is a negative sentiment for the stock.
